DDrare
Disease
Drug
Target Gene/Pathway
お問合せ先
EN
Velcade®
( DrugBank: - / KEGG DRUG: - )
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
11
重症筋無力症
1
11. 重症筋無力症
臨床試験数
:
332
/
薬物数
:
234
- (
DrugBank
:
81
) /
標的遺伝子数
:
45
-
標的パスウェイ数
:
127
10
50
100
ALL
trials per page:
Showing 1 to 1 of 1 trials
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2013-005362-19-DE
(
EUCTR
)
17/07/2014
20140717
18/12/2013
20131218
Therapy of antibody-mediated autoimmune diseases by Bortezomib (TAVAB)
Therapy of antibody-mediated autoimmune diseases by Bortezomib (TAVAB) - TAVAB
Myasthenia Gravis Systemic Lupus ErythematosusRheumatoid Arthritis;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Myasthenia Gravis Systemic Lupus ErythematosusRheumatoid Arthritis;Therapeutic area: Diseases [C] - ...
Trade Name:
Velcade®
INN or Proposed INN: BORTEZOMIB
Charité - Universitätsmedizin Berlin
NULL
Not Recruiting
Female: yes
Male: yes
18
Phase 2
Germany